GNI Hong Kong Ltd 4
4 · CATALYST BIOSCIENCES, INC. · Filed Oct 27, 2023
Insider Transaction Report
Form 4
GNI Hong Kong Ltd
10% Owner
Transactions
- Other
Common Stock
2023-10-27−5,371,304→ 0 total - Other
Series X Convertible Preferred Stock
2023-10-27−10,577→ 0 total→ Common Stock (105,770,000 underlying)
Footnotes (2)
- [F1]Represents an internal transfer by the Reporting Person, a wholly-owned indirect subsidiary of GNI Group Ltd., a company incorporated under the laws of Japan with limited liability ("GNI Japan"), to GNI Japan, pursuant to the Share Purchase Agreement, dated as of October 27, 2023, by and between the Reporting Person and GNI Japan, in exchange for consideration of $46,624,376.
- [F2]Shares of Series X Convertible Preferred Stock of the Issuer, par value $0.001 per share (the "Preferred Stock"), are convertible into shares of common stock of the Issuer at any time at the option of the holder thereof, based on the Conversion Ratio and subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for the Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on December 27, 2022).